V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206546 | 20158179 | null | 75.5 | null | 2017-06-29 | 2017-06-30 | IPILIMUMAB + NIVOLUMAB | null | null | OXALIPLATIN + MDG + PANITUMUMAB | 100757014 |
| 20206644 | 20158180 | 1.82 | 77.3 | 03 | 2018-04-18 | 2019-08-23 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | CETUXIMAB + FLUOROURACIL | 101417379 |
| 20206813 | 20158181 | 0 | 69.5 | Palliative (P) | 2018-06-04 | 2018-10-11 | BORTEZOMIB + THALIDOMIDE | N | null | FLUOROURACIL + RT | 101023740 |
| 20206966 | 20158182 | 1.58 | 105.3 | 03 | 2018-11-19 | 2019-10-16 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + PANITUMUMAB | 100343657 |
| 20207149 | 20158183 | 1.72 | 59.9 | Palliative (P) | 2018-11-29 | 2019-02-18 | Rituximab | 02 | null | OLAPARIB | 100672045 |
| 20207194 | 20158184 | 1.83 | 69.75 | null | 2018-06-24 | 2019-03-13 | Carboplatin + Pemetrexed | 02 | N | CISPLATIN + DOCETAXEL | 100428520 |
| 20207341 | 20158186 | 1.95 | 67.8 | Palliative (P) | 2017-10-28 | 2017-12-03 | SCOPE 2 TRIAL | null | N | HYDROXYCARBAMIDE | 100844603 |
| 20207351 | 20158187 | 1.54 | 84.7 | null | null | 2019-08-18 | EOF | null | null | FLUOROURACIL + STREPTOZOCIN | 101667709 |
| 20207380 | 20158188 | 1.79 | 59 | null | null | 2022-01-17 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | null | POLEM TRIAL | 101626298 |
| 20207633 | 20158189 | 1.65 | 82 | Neo-adjuvant (N) | 2017-12-15 | 2018-02-27 | Bevacizumab + Cape + Irino 21day | 02 | N | CAPECITABINE + LOMUSTINE | 101468877 |
| 20207672 | 20158190 | 1.46 | 63 | Palliative (P) | 2017-04-06 | 2017-04-17 | PACLITAXEL + RAMUCIRUMAB | 02 | N | HYDROXYCARBAMIDE | 101483646 |
| 20207716 | 20158191 | 1.77 | 55.3 | Palliative (P) | null | 2017-08-02 | PERTUZUMAB + TRASTUZUMAB | N | N | SCOPE2 TRIAL | 101534386 |
| 20207941 | 20158192 | 1.81 | 87 | null | 2020-04-03 | 2020-04-16 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | null | FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 100556932 |
| 20208048 | 20158193 | 1.86 | 69.85 | null | 2017-03-08 | 2017-09-18 | CISPLATIN + FLUOROURACIL + RT | N | null | RITUXIMAB + VENETOCLAX | 101311813 |
| 20208052 | 20158194 | 1.81 | 88 | Neo-adjuvant (N) | 2019-05-07 | 2019-05-07 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | null | null | HEPATOBLASTOMA VHR BLOCK C CARBO (AUC6.6)/DOX | 100104189 |
| 20208403 | 20158195 | 1.77 | null | null | 2021-05-07 | 2021-05-19 | Pazopanib | 2 | N | ETOPOSIDE + IFOSFAMIDE | 101228832 |
| 20208417 | 20158196 | 1.77 | 76.4 | null | 2019-11-06 | 2019-11-17 | MELPHALAN + THALIDOMIDE | 01 | null | DOCETAXEL + GEMCITABINE | 100486419 |
| 20208428 | 20158197 | 1.75 | 73.8 | null | 2018-02-06 | 2018-03-11 | DARATUMUMAB | 02 | null | POMALIDOMIDE | 101514390 |
| 20208450 | 20158198 | 1.85 | 64.4 | Palliative (P) | 2020-06-23 | 2020-07-09 | Rituximab | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 101828578 |
| 20208539 | 20158199 | 1.61 | 94.9 | null | 2015-05-04 | 2016-12-14 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | null | CTD | 101205013 |
| 20208547 | 20158200 | 1.72 | 80.9 | Palliative (P) | 2017-12-11 | 2017-12-11 | CAV | 02 | N | CISPLATIN + PEMETREXED | 101842607 |
| 20208924 | 20158203 | 1.79 | null | Adjuvant (A) | 2018-02-25 | 2018-12-28 | IBRUTINIB | 02 | null | CISPLATIN + VINORELBINE | 101629550 |
| 20209456 | 20158204 | 1.61 | null | null | 2017-09-14 | 2017-09-15 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | ARSENIC TRIOXIDE + TRETINOIN | 101338801 |
| 20209458 | 20158205 | 1.53 | 65 | Neo-adjuvant (N) | null | 2020-03-01 | Bortezomib (weekly) | Y | N | LIPOSOMAL DOXORUBICIN | 101664351 |
| 20209813 | 20158206 | 1.5 | 44.9 | Adjuvant (A) | 2016-04-14 | 2016-04-21 | Capecitabine+Cisplatin+Streptozocin | 2 | N | INTERAACT TRIAL | 101671570 |
| 20209863 | 20158207 | 1.77 | 57 | null | 2019-03-24 | 2019-03-31 | Carboplatin + Pemetrexed | 02 | null | NILOTINIB | 101409712 |
| 20209999 | 20158208 | 1.71 | 69.75 | null | 2016-05-12 | 2016-06-15 | Bendamustine + Thalidomide +/- Dex | 02 | N | CARBOPLATIN + PEMETREXED | 101760990 |
| 20210102 | 20158209 | 1.86 | 9.2 | 03 | 2022-03-30 | 2022-04-13 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + DOXORUBICIN | 101689861 |
| 20210432 | 20158211 | 1.46 | 96 | null | 2020-10-23 | 2020-11-06 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | N | CHOP R | 100377845 |
| 20210435 | 20158212 | 0.93 | 74 | Palliative (P) | 2019-04-07 | 2019-07-28 | IDELALISIB | 02 | N | RITUXIMAB | 100028847 |
| 20210468 | 20158213 | 1.53 | 68.5 | Curative (C) | 2021-12-31 | 2021-12-31 | IDARUBICIN + TRETINOIN | 2 | null | HYDROXYCARBAMIDE | 100367677 |
| 20210598 | 20158214 | 0.7 | 58 | null | 2020-11-27 | 2020-12-19 | Carboplatin + Docetaxel | null | null | EC | 100603779 |
| 20210629 | 20158215 | 1.52 | null | Palliative (P) | 2021-03-04 | 2021-03-12 | BORTEZOMIB + THALIDOMIDE | 02 | null | CARBOPLATIN + VINORELBINE | 101794725 |
| 20210893 | 20158216 | 1.58 | null | Palliative (P) | 2019-05-04 | 2019-05-04 | Cyclophosphamide High Dose | 02 | N | CAM-PLEX TRIAL | 101295603 |
| 20210918 | 20158217 | 1.56 | 69 | Curative (C) | 2016-08-12 | 2016-09-03 | Capecitabine+Cisplatin+Streptozocin | 2 | N | CAPECITABINE + OXALIPLATIN + RT | 100555649 |
| 20210988 | 20158218 | 1.75 | 62.5 | Palliative (P) | 2016-01-08 | 2018-03-22 | TOPOTECAN | 02 | N | BEAM | 101618503 |
| 20211131 | 20158219 | 1.69 | 70 | null | 2020-07-16 | 2020-07-26 | Azacitidine | 02 | null | GEMCITABINE + PACLITAXEL | 100965481 |
| 20211333 | 20158220 | 1.86 | 53.4 | null | 2018-09-19 | 2018-09-25 | CARFILZOMIB + LENALIDOMIDE | 02 | N | OLAPARIB | 101221870 |
| 20211578 | 20158221 | 1.61 | 67.6 | null | 2019-12-23 | 2019-12-31 | PERTUZUMAB + TRASTUZUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100774675 |
| 20211673 | 20158222 | 1.61 | 80 | Palliative (P) | 2018-08-16 | 2018-08-16 | Hepatoblastoma Relapse VI | 02 | null | SCOPE2 TRIAL | 100408345 |
| 20211713 | 20158223 | 1.57 | 53.4 | Palliative (P) | 2020-02-11 | 2020-04-19 | Bendamustine+Rituximab(Sub Courses) | 01 | N | EOF | 100325217 |
| 20211883 | 20158224 | 1.81 | 87 | Palliative (P) | 2017-07-14 | 2017-07-26 | CHLORAMBUCIL + RITUXIMAB | 02 | N | BACILLUS CALMETTE-GUERIN | 101557994 |
| 20212058 | 20158225 | 1.77 | 66.15 | null | 2019-11-02 | 2019-11-17 | IBRUTINIB | 02 | null | NAB-PACLITAXEL | 101481757 |
| 20212094 | 20158226 | null | null | Palliative (P) | 2019-11-20 | 2019-12-02 | ESPAC-4 TRIAL | 02 | null | AFATINIB | 100203168 |
| 20212109 | 20158227 | 1.79 | null | null | 2018-11-24 | 2019-01-10 | ECF | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 101414463 |
| 20212138 | 20158228 | null | null | null | null | 2017-12-24 | Hydroxycarbamide | null | N | BORTEZOMIB + DARATUMUMAB | 100461963 |
| 20212261 | 20158229 | 1.55 | 62.8 | null | 2021-10-12 | 2021-10-26 | SCOPE 2 TRIAL | 02 | null | BORTEZOMIB + DARATUMUMAB | 100465631 |
| 20212294 | 20158230 | 1.75 | 91 | Palliative (P) | 2019-10-29 | 2019-12-24 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100988487 |
| 20212591 | 20158231 | 1.77 | 55.2 | Palliative (P) | 2021-03-13 | 2021-03-13 | Melphalan IV High dose | 02 | N | FLUOROURACIL + RT | 101849529 |
| 20213063 | 20158232 | 1.75 | 73.4 | 03 | 2018-04-14 | 2018-04-24 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100186456 |